关键词: Dysphonia Hoarseness Systematic review Umbrella review Voice Voice disorders

来  源:   DOI:10.1016/j.jvoice.2024.03.027

Abstract:
OBJECTIVE: The aim of this study was to assess published systematic reviews that discussed noninvasive management of voice disorders. An umbrella review was conducted to collect, organize, and summarize narratively all available pharmacologic and voice therapy interventions.
METHODS: Umbrella review of systematic reviews.
METHODS: Pertinent systematic reviews were identified by searching Pubmed/Medline and Embase. A primary screen identified studies related to voice. The second round of screening focused on studies that involved noninvasive management of voice disorders such as pharmacologic or voice therapy interventions. Variables of interest included study design, number of studies included in the review, target population, method of intervention, and outcomes.
RESULTS: Forty-three systematic reviews were eligible and included in the umbrella review. Ten studies focused on pharmacologic interventions, and 33 studies focused on voice therapy. Individual studies included in the systematic reviews ranged from 2-47, with a total of 601 studies overall.
CONCLUSIONS: This study provides a detailed review of all available systematic reviews on noninvasive management of voice disorders. Explored medications included proton pump inhibitors, calcium channel blockers, tricyclic antidepressants, antibiotics, corticosteroids, and hormone replacement. Explored voice therapy techniques included hydration, vocal function exercises, laryngeal manual therapy, respiratory exercise, biofeedback, phonation, coping strategies, and others. This may be utilized to guide therapeutic decision-making and identify current gaps in the literature that may warrant future investigation.
摘要:
目的:本研究的目的是评估已发表的系统综述,这些综述讨论了语音障碍的非侵入性治疗。进行了伞式审查以收集,组织,并对所有可用的药物和语音治疗干预措施进行叙述性总结。
方法:系统综述。
方法:通过搜索Pubmed/Medline和Embase确定相关的系统评价。主要屏幕确定了与语音相关的研究。第二轮筛查的重点是涉及语音障碍的非侵入性管理的研究,例如药物或语音治疗干预。感兴趣的变量包括研究设计,审查中包括的研究数量,目标人群,干预方法,和结果。
结果:43篇系统评价符合资格,并纳入总括评价。十项研究集中在药物干预上,33项研究集中在语音治疗上。纳入系统评价的个体研究范围为2-47项,总共601项研究。
结论:本研究提供了所有关于语音障碍的非侵入性管理的系统评价的详细综述。探索的药物包括质子泵抑制剂,钙通道阻滞剂,三环抗抑郁药,抗生素,皮质类固醇,激素替代探索的语音治疗技术包括水合作用,发声功能练习,喉手法治疗,呼吸运动,生物反馈,发声,应对策略,和其他人。这可用于指导治疗决策,并确定文献中可能需要未来研究的当前空白。
公众号